GLOW is a multi‑peptide research blend that combines three well‑studied peptides — BPC‑157, TB‑500, and GHK‑Cu (a copper‑binding tripeptide) — into a single formulation to support tissue repair, skin health, and regenerative mechanisms in laboratory models.

• Components:
  • BPC‑157 – a gastric‑derived peptide studied for tissue and connective tissue healing
  • TB‑500 – a plasmatic fragment of Thymosin Beta‑4 involved in cell migration and repair pathways
  • GHK‑Cu – a copper peptide associated with collagen synthesis, dermal regeneration, and antioxidant signaling

• Form: Lyophilized (freeze‑dried) powder blend, usually offered in 70 mg vials for research use.

• Intended Use: Designed for laboratory research purposes only and not FDA‑approved for clinical, medical, cosmetic, or human use. It’s used in studies involving tissue regeneration, wound healing, connective tissue recovery, inflammation modulation, and skin remodeling.

• Mechanism: Each peptide targets distinct regenerative pathways (e.g., BPC‑157 for endothelial cells, TB‑500 for actin reorganization, and GHK‑Cu for dermal remodeling and collagen production), making GLOW suitable for comprehensive regenerative research models.